12 月 7 日，A 股 39 家生物医药公司跌幅超 5%，华东医药、恩华药业等 8家公司股价跌停，京新药业等公司跌幅超 8%。港股上市公司中国生物制药再度下跌 7.88%，石药集团下跌 4.34%。可见，此次药品集中采购对企业的业绩影响引起了市场激烈的反应。

Smallest medical device market in the MEA region. Second lowest medical device per capita in the MEA region. Market will record double-digit growth over the 2017-2022 period. Other medical devices and diagnostic imaging have the largest market shares. Imports supply almost all of the market. The healthcare sector is considered one of the best in West Africa.

Highly centralised healthcare sector, controlled by the government. One of the smallest medical device markets in the Americas region. Other medical devices, diagnostic imaging and consumables have the highest market shares. Market heavily reliant on medical device imports, particularly from Europe, China and Japan. Lack of advanced medical device manufacturing capacity. Moderate medical device market growth over the forecast period. One of the smallest per capita medical device expenditures in the region.

Ghana's pharmaceutical market is among the largest in the West African region yet remains small on a global scale. Ghana's pharmaceutical market was valued at GHS1.29bn (USD293mn) in 2017, which is fairly modest in global terms and even by regional standards, representing just under USD11 per capita. Prescription medicines dominate the market representing 73% by value, while OTC medicines occupy a considerably smaller share at 27%. The prescription market share is split relatively evenly between patented drugs and generic drugs. However, we expect the market to become increasingly penetrated by generic medicines over the long-term, somewhat eroding patented medicines' share. Pharmaceutical sales accounted for 0.5% of GDP and 13% of total healthcare expenditure in 2017.

Global migraine drugs market was valued at USD 1,745 million in 2017. The market is projected to grow at a CAGR of 18.0% over the forecast period, culminating in global sales of USD 7,766 million in 2025. Migraine drugs market has been segmented by treatment type into acute/ abortive treatment and preventive/ prophylactic treatment. Approval of novel product candidates with differentiated profile for both acute and prevention of migraine are expected to drive the growth of the global migraine market.

Most of the advanced specialist care services are available only in the Metro Manila region or other large urban areas while healthcare services outside these areas is much more rudimentary. Private for-profit healthcare services providers generally supply the highest quality services in the Philippines, as their business model allows them to raise sufficient capital to purchase the most sophisticated medical devices and pay sufficient wages to attract the highest skilled medical professionals. The Philippines is highly import dependent in the medical devices and pharmaceuticals subsectors and local manufacturers are generally limited to producing lower value-added medical devices or cheaper generic drugs.